Showing results (711-720 of 3,353) with videos related to

Sort By:
Pageof 336
The Lancet. Oncology|November 13, 2012
Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trialJohn C Mathers, Mohammad Movahedi, Finlay Macrae, et al.
The Lancet. Oncology|January 21, 2014
Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trialArun Rajan, Corey A Carter, Arlene Berman, et al.
The Lancet. Oncology|January 21, 2014
Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort studyRobert K Nam, Patrick Cheung, Sender Herschorn, et al.
The Lancet. Oncology|November 3, 2012
Supportive, palliative, and end-of-life care for patients with cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012Sheila Payne, Noreen Chan, Andrew Davies, et al.
The Lancet. Oncology|June 3, 2014
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trialJonathan Ledermann, Philipp Harter, Charlie Gourley, et al.
The Lancet. Oncology|July 2, 2014
Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysisSamir H Patel, Zhen Wang, William W Wong, et al.
The Lancet. Oncology|July 4, 2014
Drug-drug interactions with tyrosine-kinase inhibitors: a clinical perspectiveRoelof W F van Leeuwen, Teun van Gelder, Ron H J Mathijssen, et al.
The Lancet. Oncology|August 11, 2012
Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based studyLauren C Harshman, Wanling Xie, Georg A Bjarnason, et al.
The Lancet. Oncology|October 3, 2012
Pharmacogenetic biomarkers for the prediction of response to antiangiogenic treatmentBryan P Schneider, Fei Shen, Kathy D Miller
The Lancet. Oncology|October 3, 2012
Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic reviewMarije E Hamaker, Judith M Jonker, Sophia E de Rooij, et al.
Pageof 336